Treating Patients With Platelet Rich Plasma (PRP)

There are two treatments available for peripheral arterial disease, and these are called Pritikin and Permeability Factors (PFA). Pritikin is taken in tablet form, and it consists of a variety of proteins that act as a receptor for a small molecular ionic transport called Pritikin vesicles. The main ingredient of this tablet is lecithin oil. It also contains chondroitin and other substances to help it penetrate into the arterial walls. A disadvantage of Pritikin treatment is that it can cause gastrointestinal discomfort and vomiting.I strongly suggest you to visit Greensboro prp treatment to learn more about this.

Permeability Factors or PF treatment involves a protein fraction extracted from plasma proteins that have been purified using a protein selective adsorption method. The protein fraction is then combined with albumin, and a solution is applied to the membrane. The membrane is permeated with potassium and calcium, and the solute is taken up into plasma. Because the solute is carried into the arterial wall, it also helps prevent the formation of blood clots in the vessel walls. The major advantage of Permeability Factors treatment is that it can be used over many years without causing the drug to alter plasma chemistry. A major disadvantage of Permeability Factors treatment is that it does not seem to work effectively in people with high platelets, so they may not be suitable for patients with elevated risks of bleeding within the heart.

Although the exact mechanism by which or treatment increases platelet-reactive proteins in the heart is not well understood, it is thought to increase the clearance of lipids and plasma from inflammatory conditions such as heart failure, cerebrovascular disease, and other disorders. The increased clearance of lipids may be particularly useful in treating patients with end-stage liver disease, and it may be useful in preventing rejection of transplanted organs. Other areas of research are investigating the effect of prp on the immune system, such as HIV, cancer, and asthma.